Leaderboards/Vasculitis and related conditions

Vasculitis and related conditions

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Aglaia Chalkia
University of Cambridge
2
Lien Moreel
Universitair Ziekenhuis Leuven
3
Fengfan Zheng
The Affiliated Yongchuan Hospital of Chongqing Medical University
4
Jolijn R. van Leeuwen
Leiden University Medical Center
5
Rebecca A. Porritt
Sanford Burnham Prebys Medical Discovery Institute
6
Beatriz Sánchez Álamo
Instituto Cajal
7
Marieke van Nieuwland
University Medical Center Groningen
8
Michelle A. Cruz
Chestnut Health Systems
9
Yoshiya Tanaka
University of Occupational and Environmental Health Japan
10
Sabrina Arnold
University of Lübeck

Papers

1
Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis
The Lancet Rheumatology|2024
41 cit.
2
Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage
Nephrology Dialysis Transplantation|2024
38 cit.
3
Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study
Lara D. Veeken|2024
14 cit.
4
Publication in Lara D. Veeken (2024) [12 citations, W4394675062]
Lara D. Veeken|2024
12 cit.
5
Obinutuzumab in Rituximab-Intolerant Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Patients
Kidney International Reports|2025
6 cit.
6
Comparison of symptoms between diagnosis and relapse in giant cell arteritis: a retrospective cohort study
Lara D. Veeken|2024
5 cit.
7
Publication in European Journal of Nuclear Medicine and Molecular Imaging (2025) [4 citations, W4407143154]
European Journal of Nuclear Medicine and Molecular Imaging|2025
4 cit.
8
Direct comparison of the diagnostic accuracy of PET/CT, cranial MRI, ultrasound and temporal artery biopsy in giant cell arteritis
European Journal of Nuclear Medicine and Molecular Imaging|2025
4 cit.
9
Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A European Multicenter Study
Arthritis & Rheumatology|2026
4 cit.
10
Publication in Clinical & Experimental Immunology (2024) [3 citations, W4403135852]
Clinical & Experimental Immunology|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Allen R. Hendricks
The University of Texas Southwestern Medical Center
2
Chandini Rangaswamy
Universität Hamburg
3
Björn Tampe
Universitätsmedizin Göttingen
4
Peiqi Hu
University of British Columbia
5
Mark A. Ahlman
Augusta University
6
Alojzija Hočevar
Ljubljana University Medical Centre
7
Y K Onno Teng
Leiden University Medical Center
8
Giacomo Emmi
Ospedale di Cattinara
9
Kshama Mehta
Massachusetts General Hospital
10
Saori Nishio
Hokkaido University

Papers

1
Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial
Arthritis & Rheumatology|2023
116 cit.
2
Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica
Lara D. Veeken|2023
73 cit.
3
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
Annals of the Rheumatic Diseases|2024
48 cit.
4
Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica
Annals of the Rheumatic Diseases|2023
44 cit.
5
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study
The Lancet Rheumatology|2023
32 cit.
6
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
Trials|2022
30 cit.
7
Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
Frontiers in Immunology|2022
26 cit.
8
Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records
Computers in Biology and Medicine|2023
19 cit.
9
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial
BMJ Open|2022
16 cit.
10
Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma
Frontiers in Immunology|2022
15 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Gene G. Hunder
Mayo Clinic
2
Anthony S. Fauci
Georgetown University
3
Leonard H. Calabrese
Cleveland Clinic
4
D. Blöch
Centre National de la Recherche Scientifique
5
Joseph L. Mills
Baylor College of Medicine
6
David Jayne
University of Cambridge
7
Ulrich Specks
Mayo Clinic
8
J. Charles Jennette
University of North Carolina at Chapel Hill
9
Richard A. Watts
University of East Anglia
10
Peter A. Merkel
University of Pennsylvania

Papers

1
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
Arthritis & Rheumatism|1988
19.9k cit.
2
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism|2012
6.6k cit.
3
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
New England Journal of Medicine|2010
2.7k cit.
4
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Arthritis & Rheumatism|1990
2.5k cit.
5
Coronavirus Infections—More Than Just the Common Cold
JAMA|2020
2.3k cit.
6
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Proceedings of the National Academy of Sciences|1997
2k cit.
7
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
Nature|1993
1.8k cit.
8
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
New England Journal of Medicine|2010
1.7k cit.
9
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
Science|1986
1.7k cit.
10
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)
Journal of Vascular Surgery|2013
1.6k cit.

Reagents for Vasculitis and related conditions

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

Phospho-GADS (Thr262) (E8L3B) Rabbit Monoclonal Antibody

#78972$194,437
View Evidence →
Cell Signaling TechnologyEvidence 64

UBASH3B (E1A8Y) Rabbit Monoclonal Antibody

#19217$175,376
View Evidence →
Cell Signaling TechnologyEvidence 65

c-Kit (Ab81) Mouse Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#3310$465
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 60

CBX7 (E7N1W) Rabbit Monoclonal Antibody

Cited in 8 papers
#34547$175,376
View Evidence →
AbcamEvidence 63

Anti-Histone H3 (citrulline R2 + R8 + R17) antibody (ab5103)

Cited in 6 papers
#AB5103$165
View Evidence →
Cell Signaling TechnologyEvidence 66

SLAMF3/CD229 (E5E8A) Rabbit Monoclonal Antibody

#62759$175,376
View Evidence →